Caplight Directory>Companies>Hera Biotech-preview>Herabiotech


Hera Biotech

Hera Biotech

Private
San Antonio, TexasHealthcare & Life Scienceshttps://herabiotech.com

Last Round

Series A

May 3, 2025

Total Funding Raised

$11.9M

Momentum Score

25 /100

Company Overview

Hera Biotech is a biotechnology company developing a non-surgical method for the definitive diagnosis and staging of endometriosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

endometriosis diagnosisnon-surgical diagnosisendometriosis testwomen's health diagnosticsendometriosis staginglab-developed testLDTlaparoscopic surgery alternativeFemTechcervical cancer diagnosticpoint-of-care diagnosticbiomarker assayswomen's health techgene expression analysisOB/GYN diagnosticsmedical devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hera Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hera Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 3, 2025
SeedAug 24, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Somer Baburek

Co-Founder, CEO, President

Founding Team

Cinzia Donato

COO

Executive Team

Hera Biotech Investors

Notable investors and investment history

InvestorRounds
Kendra Scott Women's Entrepreneurial Leadership InstituteSeed
Coyote VenturesSeed
AltheaSeed
View all Investors

Hera Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hera Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hera Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Antonio, Texas
Employee Range11
Year Founded2020
Last FundingMay 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.